Molecular biology of toll-like receptors

General Physiology and Biophysics

Volumn 31, Issue 4, 2012, Pages 357-366

  Szatmary, Zoltan ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Adaptor; Anti viral response; Inflammation; Signal transduction; Toll like receptor

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN CONJUGATING ENZYME 13; UNINDEXED DRUG;

AMINO ACID SEQUENCE; BINDING SITE; CYTOKINE RESPONSE; DIMERIZATION; ENZYME ACTIVATION; HUMAN; INFLAMMATION; MOLECULAR BIOLOGY; NONHUMAN; OSTEOLYSIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; UBIQUITINATION; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; MONONUCLEAR PHAGOCYTE;

FUNGI; PROTOZOA;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MONONUCLEAR PHAGOCYTE SYSTEM; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84874674758     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2012_048     Document Type: Review

References (70)

1. Akira S. (2003): Toll-like receptor signaling. J. Biol. Chem. 278, 38105-38108 http://dx.doi.org/10.1074/jbc.R300028200.
2. Aliprantis A. O., Yang R. B., Mark M. R., Suggett S., Devaux B., Radolf J. D., Klimpel G. R., Godowski P., Zychlinsky A. (1999): Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739 http://dx.doi.org/10.1126/science.285.5428.736.
3. Andrejeva J., Childs K. S., Young D. F., Carlos T. S., Stock N., Goodbourn S., Randall R. E. (2004): The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101, 17264-17269 http://dx.doi.org/10. 1073/pnas.0407639101.
4. Arancibia S. A., Beltran C. J., Aguirre I. M., Silva P., Peralta A. L., Malinarich F., Hermoso M. A. (2007): Toll-like receptors are key participants in innate immune responses. Biol. Res. 40, 97-112 http://dx.doi.org/10.4067/S0716- 97602007000200001.
5. Bignell G. R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P. J., Lakhani S. R., Jones C., Hansen J., Blair E., Hofmann B., Siebert R., Turner G., Evans D. G., Schrander-Stumpel C., Beemer F. A., van Den Ouweland A., Halley D., Delpech B., Cleveland M. G., Leigh I., Leisti J., Rasmussen S. (2000): Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25, 160-165 http://dx.doi.org/10.1038/76006.
6. Brummelkamp T. R., Nijman S. M., Dirac A. M., Bernards R. (2003): Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424, 797-801 http://dx.doi.org/10.1038/nature01811.
7. Carty M., Goodbody R., Schroder M., Stack J., Moynagh P. N., Bowie A. G. (2006): The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7, 1074-1081 http://dx.doi.org/10.1038/ni1382.
8. Chuang T. H., Ulevitch R. J. (2004): Triad3A, an E3 ubiquitinprotein ligase regulating Toll-like receptors. Nat. Immunol. 5, 495-502 http://dx.doi.org/10.1038/ni1066.
9. Ciechanover A. (2006): Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Exp. Biol. Med. (Maywood) 231, 1197-1211.
10. Cusson-Hermance N., Khurana S., Lee T. H., Fitzgerald K. A., Kelliher M. A. (2005): Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem. 280, 36560-36566 http://dx.doi.org/10.1074/jbc. M506831200.
11. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z. J. (2000): Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 http://dx.doi.org/10.1016/S0092-8674(00) 00126-4.
12. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R., Cheng G. (2002): IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263 http://dx.doi.org/10.1016/S1074-7613(02)00390-4.
13. Doyle S. L., O'Neill L. A. (2006): Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72, 1102-1113 http://dx.doi.org/10.1016/j.bcp. 2006.07.010.
14. Dunne A., O'Neill L. A. (2005): Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett. 579, 3330-3335 http://dx.doi.org/10.1016/j. febslet.2005.04.024.
15. Evans P. C. (2005): Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for antiinflammatory drugs. Expert Rev. Mol. Med. 7, 1-19 http://dx.doi.org/10.1017/S1462399405009415.
16. Fitzgerald K. A., Palsson-McDermott E. M., Bowie A. G., Jefferies C. A., Mansell A. S., Brady G., Brint E., Dunne A., Gray P., Harte M. T., McMurray D., Smith D. E., Sims J. E., Bird T. A., O'Neill L. A. (2001): Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83 http://dx.doi.org/10.1038/35092578.
17. Fitzgerald K. A., McWhirter S. M., Faia K. L., Rowe D. C., Latz E., Golenbock D. T., Coyle A. J., Liao S. M., Maniatis T. (2003): IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 http://dx.doi.org/10.1038/ni921.
18. Fukushima T., Matsuzawa S., Kress C. L., Bruey J. M., Krajewska M., Lefebvre S., Zapata J. M., Ronai Z., Reed J. C. (2007): Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 104, 6371-6376 http://dx.doi.org/10.1073/pnas.0700548104.
19. Gewirtz A. T., Navas T. A., Lyons S., Godowski P. J., Madara J. L. (2001): Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885.
20. Gohda J., Matsumura T., Inoue J. (2004): Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor- inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173, 2913-2917.
21. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L. C., Wang G. G., Kamps M. P., Raz E., Wagner H., Hacker G., Mann M., Karin M. (2006): Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 http://dx.doi.org/10.1038/nature04369.
22. Hansson G. K., Edfeldt K. (2005): Toll to be paid at the gateway to the vessel wall. Arterioscler. Thromb. Vasc. Biol. 25, 1085-1087 http://dx.doi.org/10.1161/01.ATV.0000168894.43759.47.
23. Hayashi F., Smith K. D., Ozinsky A., Hawn T. R., Yi E. C., Goodlett D. R., Eng J. K., Akira S., Underhill D. M., Aderem A. (2001): The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 http://dx.doi.org/10.1038/35074106.
24. Hiscott J. (2007): Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18, 483-490 http://dx.doi.org/10.1016/j.cytogfr.2007.06.002.
25. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S. O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., Beutler B. (2003): Identification of Lps2 as a key transducer of MyD88- independent TIR signalling. Nature 424, 743-748 http://dx.doi.org/10.1038/nature01889.
26. Horng T., Barton G. M., Medzhitov R. (2001): TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841 http://dx.doi.org/10. 1038/ni0901-835.
27. Hsu L. C., Park J. M., Zhang K., Luo J. L., Maeda S., Kaufman R. J., Eckmann L., Guiney D. G., Karin M. (2004): The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428, 341-345 http://dx.doi.org/10.1038/nature02405.
28. Jaattela M., Mouritzen H., Elling F., Bastholm L. (1996): A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156, 1166-1173.
29. Janssens S., Beyaert R. (2003): Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293-302 http://dx.doi.org/10.1016/S1097-2765(03)00053-4.
30. Kawagoe T., Sato S., Jung A., Yamamoto M., Matsui K., Kato H., Uematsu S., Takeuchi O., Akira S. (2007): Essential role of IRAK-4 protein and its kinase activity in Toll-like receptormediated immune responses but not in TCR signaling. J. Exp. Med. 204, 1013-1024 http://dx.doi.org/10.1084/jem.20061523.
31. Kawagoe T., Sato S., Matsushita K., Kato H., Matsui K., Kumagai Y., Saitoh T., Kawai T., Takeuchi O., Akira S. (2008): Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9, 684-691 http://dx.doi.org/10.1038/ni.1606.
32. Kawai T., Sato S., Ishii K. J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J., Uematsu S., Takeuchi O., Akira S. (2004): Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061-1068 http://dx.doi.org/10.1038/ni1118.
33. Kawai T., Akira S. (2005): Toll-like receptor downstream signaling. Arthritis Res. Ther. 7, 12-19 http://dx.doi.org/10.1186/ar1469.
34. Kim S., Takahashi H., Lin W. W., Descargues P., Grivennikov S., Kim Y., Luo J. L., Karin M. (2009): Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106 http://dx.doi.org/10. 1038/nature07623.
35. Kobayashi K., Hernandez L. D., Galan J. E., Janeway C. A. Jr., Medzhitov R., Flavell R. A. (2002): IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 http://dx.doi.org/10.1016/S0092-8674(02)00827-9.
36. Kollewe C., Mackensen A. C., Neumann D., Knop J., Cao P., Li S., Wesche H., Martin M. U. (2004): Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J. Biol. Chem. 279, 5227-5236 http://dx.doi.org/10.1074/jbc.M309251200.
37. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. (2003): The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424, 801-805 http://dx.doi.org/10.1038/ nature01802.
38. Lemaitre B., Nicolas E., Michaut L., Reichhart J. M., Hoffmann J. A. (1996): The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983 http://dx.doi.org/10.1016/S0092-8674(00)80172-5.
39. Leung T. H., Hoffmann A., Baltimore D. (2004): One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118, 453-464 http://dx.doi.org/10.1016/j.cell.2004.08.007.
40. Li X., Commane M., Burns C., Vithalani K., Cao Z., Stark G. R. (1999): Mutant cells that do not respond to interleukin-1 (IL- 1) reveal a novel role for IL-1 receptor-associated kinase. Mol. Cell. Biol. 19, 4643-4652.
41. Lin W. W., Karin M. (2007): A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183 http://dx.doi.org/10.1172/JCI31537.
42. Luo J. L., Maeda S., Hsu L. C., Yagita H., Karin M. (2004): Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6, 297-305 http://dx.doi.org/10.1016/j.ccr.2004.08.012.
43. Mansell A., Smith R., Doyle S. L., Gray P., Fenner J. E., Crack P. J., Nicholson S. E., Hilton D. J., O'Neill L. A., Hertzog P. J. (2006): Suppressor of cytokine signaling 1 negatively regulates Tolllike receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155 http://dx.doi.org/10.1038/ ni1299.
44. Matsuzawa A., Tseng P. H., Vallabhapurapu S., Luo J. L., Zhang W., Wang H., Vignali D. A., Gallagher E., Karin M. (2008): Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663-668 http://dx.doi.org/10.1126/science.1157340.
45. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., Tschopp J. (2004): RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5, 503-507 http://dx.doi.org/10. 1038/ni1061.
46. Miggin S. M., O'Neill L. A. (2006): New insights into the regulation of TLR signaling. J. Leukoc. Biol. 80, 220-226 http://dx.doi.org/10.1189/jlb. 1105672.
47. Naiki Y., Michelsen K. S., Zhang W., Chen S., Doherty T. M., Arditi M. (2005): Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J. Biol. Chem. 280, 5491-5495 http://dx.doi.org/10.1074/jbc.C400503200.
48. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., Takayanagi H., Ohba Y., Taniguchi T., Honda K. (2006): Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptordependent gene induction program. Proc. Natl. Acad. Sci. U.S.A. 103, 15136-15141 http://dx.doi.org/10.1073/pnas.0607181103.
49. Nizet V. (2006): Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 8, 11-26.
50. O'Neill L. A. (2002): Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol. 23, 296-300 http://dx.doi.org/10.1016/S1471-4906(02)02222-6.
51. O'Neill L. A. (2006): How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9 http://dx.doi.org/10.1016/j. coi.2005.11.012.
52. Opipari A. W. Jr., Hu H. M., Yabkowitz R., Dixit V. M. (1992): The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267, 12424-12427.
53. Pietras E. M., Saha S. K., Cheng G. (2006): The interferon response to bacterial and viral infections. J. Endotoxin Res. 12, 246-250 http://dx.doi.org/10.1179/096805106X118799.
54. Sasai M., Oshiumi H., Matsumoto M., Inoue N., Fujita F., Nakanishi M., Seya T. (2005): Cutting Edge: NF-kappaB-activating kinaseassociated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J. Immunol. 174, 27-30.
55. Szatmary Z., Kebis A. (2012): Promoter-context as a determinant of glucocorticoid receptor-responsiveness to activation of p38 and JNK mitogen-activated protein (MAP) kinases. Gen. Physiol. Biophys. 31, 309-322 http://dx.doi.org/10.4149/gpb-2012-036.
56. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S., Honda K., Ohba Y., Mak T. W., Taniguchi T. (2005): Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243-249 http://dx.doi.org/10.1038/nature03308.
57. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., Yokochi T., Oda H., Nakamura K., Ida N., Wagner E. F., Taniguchi T. (2002): RANKL maintains bone homeostasis through c-Fosdependent induction of interferon-beta. Nature 416, 744-749 http://dx.doi.org/10.1038/416744a.
58. Takayanagi H., Sato K., Takaoka A., Taniguchi T. (2005): Interplay between interferon and other cytokine systems in bone metabolism. Immunol. Rev. 208, 181-193 http://dx.doi.org/10.1111/j.0105-2896.2005.00337.x.
59. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. (2003): CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793-796 http://dx.doi.org/10.1038/nature01803.
60. Tseng P. H., Matsuzawa A., Zhang W., Mino T., Vignali D. A., Karin M. (2010): Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75 http://dx.doi.org/10.1038/ni.1819.
61. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., Matsuda M., Coban C., Ishii K. J., Kawai T., Takeuchi O., Akira S. (2005): Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 201, 915-923 http://dx.doi.org/10.1084/jem.20042372.
62. Ulevitch R. J. (1999): Toll gates for pathogen selection. Nature 401, 755-756 http://dx.doi.org/10.1038/44490.
63. Underhill D. M., Ozinsky A., Hajjar A. M., Stevens A., Wilson C. B., Bassetti M., Aderem A. (1999): The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811-815 http://dx.doi.org/10.1038/44605.
64. Wang C., Deng L., Hong M., Akkaraju G. R., Inoue J., Chen Z. J. (2001): TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 http://dx.doi.org/10.1038/35085597.
65. Watters T. M., Kenny E. F., O'Neill L. A. (2007): Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 85, 411-419 http://dx.doi.org/10.1038/sj.icb.7100095.
66. Wietek C., Miggin S. M., Jefferies C. A., O'Neill L. A. (2003): Interferon regulatory factor-3-mediated activation of the interferon- sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278, 50923-50931 http://dx.doi.org/10.1074/ jbc.M308135200.
67. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. (2002): Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672.
68. Yamamoto M., Okamoto T., Takeda K., Sato S., Sanjo H., Uematsu S., Saitoh T., Yamamoto N., Sakurai H., Ishii K. J., Yamaoka S., Kawai T., Matsuura Y., Takeuchi O., Akira S. (2006): Key function for the Ubc13 E2 ubiquitin- conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962-970 http://dx.doi.org/10.1038/ni1367.
69. Yamin T. T., Miller D. K. (1997): The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272, 21540-21547 http://dx.doi.org/10.1074/jbc.272.34.21540.
70. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. (2004): The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 http://dx.doi.org/10.1038/ni1087.